This bodies well for the future of mRNA vaccines for cancer and room to rev up our immune system vs cancer to improve outcomes
The 1st randomized trial of an mRNA cancer vaccine to show efficacy: Stage III/IV melanoma, a combination immunotherapy + vaccine was superior to immunotherapy alone for recurrence-free survival.
157 participants (Phase 2b) w/ large trial planned
